Growth Metrics

Cerus (CERS) Cash from Investing Activities Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -253.01%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -11.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -41.67%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -111.03%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -40.94%
10 Cerus 549.42 Mn 469.73 Mn 27.89 Mn 99.92%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 99.92%
Dec 31, 2025 -29.80%
Sep 30, 2025 -6.69%
Jun 30, 2025 41.63%
Mar 31, 2025 -28.82%
Dec 31, 2024 43.45%
Sep 30, 2024 -39.48%
Jun 30, 2024 -39.61%
Mar 31, 2024 -59.26%
Dec 31, 2023 2.62%
Sep 30, 2023 62.89%
Jun 30, 2023 51.25%
Mar 31, 2023 67.99%
Dec 31, 2022 -7.74%
Sep 30, 2022 -30.18%
Jun 30, 2022 -7.32%
Mar 31, 2022 -13.20%
Dec 31, 2021 -96.39%
Sep 30, 2021 244.82%
Jun 30, 2021 50.91%
Mar 31, 2021 35.32%
Dec 31, 2020 53.96%
Sep 30, 2020 24.16%
Jun 30, 2020 -28.79%
Mar 31, 2020 -121.34%
Dec 31, 2019 -20.48%
Sep 30, 2019 -7.23%
Jun 30, 2019 10.08%
Mar 31, 2019 31.86%
Dec 31, 2018 -32.02%
Sep 30, 2018 -72.85%
Jun 30, 2018 -33.69%
Mar 31, 2018 11.97%
Dec 31, 2017 -7.96%
Sep 30, 2017 -36.37%
Jun 30, 2017 70.05%
Mar 31, 2017 23.66%
Dec 31, 2016 253.28%
Sep 30, 2016 34.38%
Jun 30, 2016 -231.63%
Mar 31, 2016 -1,101.41%
Dec 31, 2015 1,080.11%
Sep 30, 2015 812.07%
Jun 30, 2015 737.39%
Mar 31, 2015 -595.66%
Dec 31, 2014 -148.87%
Sep 30, 2014 -259.89%
Jun 30, 2014 409.24%
Mar 31, 2014 164.05%
Dec 31, 2013 15.39%
Sep 30, 2013 -295.67%